Hinova Pharmaceuticals, Inc.

Q: What is Hinova Pharmaceuticals's industry?

Hinova Pharmaceuticalsis in the industry of: Pharmaceutical and Medicine Manufacturing, Research and Development in the Physical, Engineering, and Life Sciences

Q: Where is Hinova Pharmaceuticals's headquarters?

Hinova Pharmaceuticals is located in China, Sichuan.

Q: What is Hinova Pharmaceuticals's NAICS code?

Hinova Pharmaceuticals's NAICS: SHA.

Public Company

Follow View Corporate Tree Create Alert

http://www.hinovapharma.com/

Hinova Pharmaceuticals is a company that provides Health care, Prostate cancer, Androgen receptor and more. Hinova Pharmaceuticals is headquartered in China Sichuan. Hinova Pharmaceuticals was foundedMore

Basic Info

Legal Name

Hinova Pharmaceuticals, Inc.

Founded Year

2013

Headquarter

Sichuan, China

Core Members

Yuanwei ChenFounder and Chief Executive Officer

Xinghai LiCo-Founder and Chief Scientific Officer

Frank PeraboChief Medical Officer

Topics

Health careProstate cancerAndrogen receptorDarolutamideEnzalutamideApalutamideAntagonismDrugProcess researchBiopharmaceuticalMedicinal chemistryBreast cancerDrug discoveryClinical research

Data Snapshot

Funding Round

Total Funding Rounds

$ 219.26 M

Total Amount

Literature

Total Publications

$ 0

Total Citations

Top Related Companies

Hinova Pharmaceuticals Frequently Asked Questions

What is Hinova Pharmaceuticals's industry?

Hinova Pharmaceuticals is in the industry of: Pharmaceutical and Medicine ManufacturingResearch and Development in the Physical, Engineering, and Life Sciences

What technical fields has Hinova Pharmaceuticals researched?

Hinova Pharmaceuticals has researched the technical fields related to Health careProstate cancerAndrogen receptorDarolutamideEnzalutamideApalutamideAntagonismDrugProcess researchBiopharmaceuticalMedicinal chemistryBreast cancerDrug discoveryClinical research

What kind of company is Hinova Pharmaceuticals?

Hinova Pharma is an innovative drug research and development manufacturer that provides users with compound HC-1119 androgen receptor (AR) antagonism by...